Hascovir Lipożel (Aciclovir)

Hascovir Lipożel is a topical gel that contains the antiviral agent aciclovir. It is marketed in the European Union as an over‑the‑counter (OTC) product for external use. The formulation delivers aciclovir directly to the skin, targeting herpes simplex virus infections. As a gel, it is applied to the affected area and is intended for short‑term treatment of cold sores and related visible minor skin lesions.

Hascovir Lipożel is indicated for the topical treatment of certain herpes simplex virus skin conditions.

- Herpes labialis (cold sores) on the lips or perioral area, applied at the first sign of tingling or redness. - Primary or recurrent herpes simplex infections of the skin, including facial or extrafacial sites, to help control lesion development. - Minor epithelial lesions caused by HSV on the face, such as papules or vesicles, to promote faster healing. - Early‑stage HSV lesions to reduce symptom duration and viral shedding when treatment is started promptly. - Adjunctive therapy for HSV‑related discomfort, used alongside other supportive measures as recommended.

Side effects of Hascovir Lipożel are generally mild, reflecting its local application, but rare serious reactions can occur.

Common: - Mild skin irritation or redness at the application site. - Itching or a slight burning sensation. - Dryness or peeling of the treated skin.

Serious: - Allergic contact dermatitis with swelling, rash, or blistering. - Severe skin ulceration or necrosis (very rare). - Systemic hypersensitivity reactions such as urticaria or angioedema.

Before using Hascovir Lipożel, consider the following precautions to ensure safe and effective application.

- Do not apply to mucous membranes, eyes, or broken skin beyond the target lesion. - Avoid use on extensive or deep ulcerated areas without medical advice. - Discontinue use if signs of an allergic reaction develop. - Keep the gel out of reach of children; accidental ingestion may cause systemic effects. - Consult a healthcare professional if the lesion worsens, spreads, or does not improve within a typical timeframe. - Pregnant or breastfeeding individuals should seek medical guidance before use.

Hascovir Lipożel may interact with other topical agents or systemic antivirals; consider the following guidance.

Avoid: - Concurrent application of other topical medications containing irritants (e.g., retinoids, corticosteroids) on the same area without professional advice. - Use on skin treated with chemical peels or laser therapy until healed.

Use with caution: - Systemic aciclovir or valacyclovir therapy, as combined antiviral exposure may increase risk of systemic side effects. - Use with other over‑the‑counter skin products (e.g., moisturizers) that could alter absorption; apply gel first and allow it to dry. - Patients with known hypersensitivity to aciclovir or any gel excipients should avoid use or proceed only under supervision.